Kate Sasser, Ph.D.

Dr. Kate Sasser is the Chief Scientific Officer of Tempus. Dr. Sasser brings over 20 years of experience in translational research and precision medicine in biological sciences across academia and the pharmaceutical and biotechnology industries. Prior to Tempus, she led the translational research, precision medicine, and research & development operations organizations within Genmab, a biotechnology company focused on developing transformative antibody therapeutics as medicine.